First Pacific Advisors’s Maravai LifeSciences MRVI Stock Holding History

First Pacific Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.5M	Hold	884,883	–	–	0.04%	60
2025 Q4	$2.88M	Hold	884,883	–	–	0.04%	52
2025 Q3	$2.54M	Buy	884,883 +143,551	+19%	+$367K	0.04%	51
2025 Q2	$1.79M	Buy	+741,332	New	+$1.56M	0.03%	57

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Pacific Advisors's MRVI Position: Q1 2026 in Review

First Pacific Advisors held its Maravai LifeSciences (MRVI) position steady in Q1 2026 at 884,883 shares worth $2.5M. The position accounts for 0.04% of the portfolio, ranked #60.

First Pacific Advisors first reported a position in MRVI in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.88M in Q4 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

First Pacific Advisors held 884,883 shares of Maravai LifeSciences worth $2.5M as of Q1 2026.
First Pacific Advisors left its Maravai LifeSciences share count unchanged in Q1 2026.
Maravai LifeSciences made up 0.04% of First Pacific Advisors's portfolio in Q1 2026, its #60 holding.
First Pacific Advisors first reported a position in Maravai LifeSciences in Q2 2025 and has held it in 4 quarters since.
First Pacific Advisors's Maravai LifeSciences position peaked at $2.88M in Q4 2025.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on First Pacific Advisors's 13F filing for Q1 2026, filed 14 May 2026.